{"count": 7, "results": [{"_id": "34440899", "pmid": 34440899, "pmcid": "PMC8394782", "title": "Metformin and Glaucoma:Review of Anti-Fibrotic Processes and Bioenergetics", "journal": "Cells", "authors": ["Hurley DJ", "Irnaten M", "O'Brien C"], "date": "2021-08-19T00:00:00Z", "doi": "10.3390/cells10082131", "meta_date_publication": "2021 Aug 19", "meta_volume": "10", "meta_issue": "8", "meta_pages": "", "score": 50282.348, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@Glaucoma@@@:Review of Anti-Fibrotic Processes and Bioenergetics", "citations": {"NLM": "Hurley DJ, Irnaten M, O'Brien C. Metformin and Glaucoma:Review of Anti-Fibrotic Processes and Bioenergetics Cells. 2021 Aug 19;10(8):. PMID: 34440899", "BibTeX": "@article{34440899, title={Metformin and Glaucoma:Review of Anti-Fibrotic Processes and Bioenergetics}, author={Hurley DJ and Irnaten M and O'Brien C}, journal={Cells}, volume={10}, number={8}}"}}, {"_id": "38536124", "pmid": 38536124, "title": "Metformin in Glaucoma Treatment.", "journal": "J Glaucoma", "authors": ["Daka Q", "Neziri B", "Lindner E", "Azuara Blanco A"], "date": "2024-03-28T00:00:00Z", "doi": "10.1097/IJG.0000000000002387", "meta_date_publication": "2024 Mar 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50282.22, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@Glaucoma@@@ Treatment.", "citations": {"NLM": "Daka Q, Neziri B, Lindner E, Azuara Blanco A. Metformin in Glaucoma Treatment. J Glaucoma. 2024 Mar 28;():. PMID: 38536124", "BibTeX": "@article{38536124, title={Metformin in Glaucoma Treatment.}, author={Daka Q and Neziri B and Lindner E and Azuara Blanco A}, journal={J Glaucoma}}"}}, {"_id": "34708800", "pmid": 34708800, "pmcid": "PMC8725087", "title": "Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study", "journal": "Indian J Ophthalmol", "authors": ["George R", "Asokan R", "Vijaya L"], "date": "2021-11-01T00:00:00Z", "doi": "10.4103/ijo.IJO_1486_21", "meta_date_publication": "2021 Nov", "meta_volume": "69", "meta_issue": "11", "meta_pages": "3336-3338", "score": 50260.383, "text_hl": "Studies have reported the usage of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ being associated with the reduced risk of progression of @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@. ", "citations": {"NLM": "George R, Asokan R, Vijaya L. Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study Indian J Ophthalmol. 2021 Nov;69(11):3336-3338. PMID: 34708800", "BibTeX": "@article{34708800, title={Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study}, author={George R and Asokan R and Vijaya L}, journal={Indian J Ophthalmol}, volume={69}, number={11}, pages={3336-3338}}"}}, {"_id": "39182626", "pmid": 39182626, "title": "Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.", "journal": "Ophthalmology", "authors": ["Muayad J", "Loya A", "Hussain ZS", "Chauhan MZ", "Alsoudi AF", "De Francesco T", "Ike K Ahmed I"], "date": "2024-08-23T00:00:00Z", "doi": "10.1016/j.ophtha.2024.08.023", "meta_date_publication": "2024 Aug 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.39, "text_hl": "Comparative Effects of GLP-1 Receptor Agonists and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@Glaucoma@@@ Risk in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ @SPECIES_9606 @@@Patients@@@.", "citations": {"NLM": "Muayad J, Loya A, Hussain ZS, Chauhan MZ, Alsoudi AF, De Francesco T, Ike K Ahmed I. Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients. Ophthalmology. 2024 Aug 23;():. PMID: 39182626", "BibTeX": "@article{39182626, title={Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.}, author={Muayad J and Loya A and Hussain ZS and Chauhan MZ and Alsoudi AF and De Francesco T and Ike K Ahmed I}, journal={Ophthalmology}}"}}, {"_id": "32903813", "pmid": 32903813, "pmcid": "PMC7438907", "title": "Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats via Activating AMPK/Nrf2 Signaling Pathway", "journal": "Front Pharmacol", "authors": ["Li X", "Leng Y", "Jiang Q", "Wang Z", "Luo P", "Zhang C", "Chen L", "Wang Y", "Wang H", "Yue X", "Shen C", "Zhou Y", "Shi C", "Xie L"], "date": "2020-07-31T00:00:00Z", "doi": "10.3389/fphar.2020.01038", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "1038", "score": 50252.38, "text_hl": "Eye Drops of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Prevents @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@Fibrosis@@@ After @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@Glaucoma@@@ Filtration Surgery in @SPECIES_10116 @@@Rats@@@ via Activating @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@/@GENE_NFE2L2 @GENE_83619 @@@Nrf2@@@ Signaling Pathway", "citations": {"NLM": "Li X, Leng Y, Jiang Q, Wang Z, Luo P, Zhang C, Chen L, Wang Y, Wang H, Yue X, Shen C, Zhou Y, Shi C, Xie L. Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats via Activating AMPK/Nrf2 Signaling Pathway Front Pharmacol. 2020;11():1038. PMID: 32903813", "BibTeX": "@article{32903813, title={Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats via Activating AMPK/Nrf2 Signaling Pathway}, author={Li X and Leng Y and Jiang Q and Wang Z and Luo P and Zhang C and Chen L and Wang Y and Wang H and Yue X and Shen C and Zhou Y and Shi C and Xie L}, journal={Front Pharmacol}, volume={11}, pages={1038}}"}}, {"_id": "29746333", "pmid": 29746333, "title": "Effect of Diabetes Mellitus and Metformin on Central Corneal Endothelial Cell Density in Eye Bank Eyes.", "journal": "Cornea", "authors": ["Chocron IM", "Rai DK", "Kwon JW", "Bernstein N", "Hu J", "Heo M", "Lee JK", "Gore PK", "McCartney MD", "Chuck RS"], "date": "2018-08-01T00:00:00Z", "doi": "10.1097/ICO.0000000000001623", "meta_date_publication": "2018 Aug", "meta_volume": "37", "meta_issue": "8", "meta_pages": "964-966", "score": 50053.6, "text_hl": "Lower ECD was not associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use except in a subgroup of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@, in which subgroup analysis showed lower ECD. ", "citations": {"NLM": "Chocron IM, Rai DK, Kwon JW, Bernstein N, Hu J, Heo M, Lee JK, Gore PK, McCartney MD, Chuck RS. Effect of Diabetes Mellitus and Metformin on Central Corneal Endothelial Cell Density in Eye Bank Eyes. Cornea. 2018 Aug;37(8):964-966. PMID: 29746333", "BibTeX": "@article{29746333, title={Effect of Diabetes Mellitus and Metformin on Central Corneal Endothelial Cell Density in Eye Bank Eyes.}, author={Chocron IM and Rai DK and Kwon JW and Bernstein N and Hu J and Heo M and Lee JK and Gore PK and McCartney MD and Chuck RS}, journal={Cornea}, volume={37}, number={8}, pages={964-966}}"}}, {"_id": "29338275", "pmid": 29338275, "title": "Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study.", "journal": "Acta Med Acad", "authors": ["Maleškić S", "Kusturica J", "Gušić E", "Rakanović-Todić M", "Šečić D", "Burnazović-Ristić L", "Kulo A"], "date": "2017-11-01T00:00:00Z", "doi": "10.5644/ama2006-124.196", "meta_date_publication": "2017 Nov", "meta_volume": "46", "meta_issue": "2", "meta_pages": "116-123", "score": 50048.586, "text_hl": "CONCLUSION: Our results suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may have a protective effect on @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@ocular complications@@@, especially @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@, in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D.@@@ The effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ either regarding prevention of @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@ocular complications@@@ or @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@ocular complications@@@ already developed in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@, should be further investigated.", "citations": {"NLM": "Maleškić S, Kusturica J, Gušić E, Rakanović-Todić M, Šečić D, Burnazović-Ristić L, Kulo A. Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study. Acta Med Acad. 2017 Nov;46(2):116-123. PMID: 29338275", "BibTeX": "@article{29338275, title={Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study.}, author={Maleškić S and Kusturica J and Gušić E and Rakanović-Todić M and Šečić D and Burnazović-Ristić L and Kulo A}, journal={Acta Med Acad}, volume={46}, number={2}, pages={116-123}}"}}]}